361 related articles for article (PubMed ID: 17512622)
1. Engineering antibodies for clinical applications.
Jain M; Kamal N; Batra SK
Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622
[TBL] [Abstract][Full Text] [Related]
2. Antibody engineering and modification technologies.
Filpula D
Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
[TBL] [Abstract][Full Text] [Related]
3. Engineered antibodies take center stage.
Huston JS; George AJ
Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
[TBL] [Abstract][Full Text] [Related]
4. Engineering of therapeutic antibodies to minimize immunogenicity and optimize function.
Presta LG
Adv Drug Deliv Rev; 2006 Aug; 58(5-6):640-56. PubMed ID: 16904789
[TBL] [Abstract][Full Text] [Related]
5. Engineered protein scaffolds as next-generation antibody therapeutics.
Gebauer M; Skerra A
Curr Opin Chem Biol; 2009 Jun; 13(3):245-55. PubMed ID: 19501012
[TBL] [Abstract][Full Text] [Related]
6. Antibodies and genetically engineered related molecules: production and purification.
Roque AC; Lowe CR; Taipa MA
Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
[TBL] [Abstract][Full Text] [Related]
7. Antibody therapeutics, antibody engineering, and the merits of protein stability.
Demarest SJ; Glaser SM
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
[TBL] [Abstract][Full Text] [Related]
8. Intracellular antibodies (intrabodies) and their therapeutic potential.
Lo AS; Zhu Q; Marasco WA
Handb Exp Pharmacol; 2008; (181):343-73. PubMed ID: 18071953
[TBL] [Abstract][Full Text] [Related]
9. Intrabodies as drug discovery tools and therapeutics.
Stocks M
Curr Opin Chem Biol; 2005 Aug; 9(4):359-65. PubMed ID: 15979379
[TBL] [Abstract][Full Text] [Related]
10. Introduction to current and future protein therapeutics: a protein engineering perspective.
Carter PJ
Exp Cell Res; 2011 May; 317(9):1261-9. PubMed ID: 21371474
[TBL] [Abstract][Full Text] [Related]
11. Antibody engineering principles and applications.
Loo L; Robinson MK; Adams GP
Cancer J; 2008; 14(3):149-53. PubMed ID: 18536554
[TBL] [Abstract][Full Text] [Related]
12. Leveraging SBDD in protein therapeutic development: antibody engineering.
Gilliland GL; Luo J; Vafa O; Almagro JC
Methods Mol Biol; 2012; 841():321-49. PubMed ID: 22222459
[TBL] [Abstract][Full Text] [Related]
13. Tailor-made antibody therapeutics.
Chowdhury PS; Wu H
Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
[TBL] [Abstract][Full Text] [Related]
14. The biotechnology and applications of antibody engineering.
Rapley R
Mol Biotechnol; 1995 Apr; 3(2):139-54. PubMed ID: 7620975
[TBL] [Abstract][Full Text] [Related]
15. Antibody evolution beyond Nature.
Borrebaeck CA; Ohlin M
Nat Biotechnol; 2002 Dec; 20(12):1189-90. PubMed ID: 12454662
[No Abstract] [Full Text] [Related]
16. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
Nygren PA
FEBS J; 2008 Jun; 275(11):2668-76. PubMed ID: 18435759
[TBL] [Abstract][Full Text] [Related]
17. Clinical issues in antibody design.
Chester KA; Hawkins RE
Trends Biotechnol; 1995 Aug; 13(8):294-300. PubMed ID: 7662305
[TBL] [Abstract][Full Text] [Related]
18. Discovering and improving novel peptide therapeutics.
McGregor DP
Curr Opin Pharmacol; 2008 Oct; 8(5):616-9. PubMed ID: 18602024
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic advances in rheumatology with the use of recombinant proteins.
Rothe A; Power BE; Hudson PJ
Nat Clin Pract Rheumatol; 2008 Nov; 4(11):605-14. PubMed ID: 18813220
[TBL] [Abstract][Full Text] [Related]
20. Molecular engineering and design of therapeutic antibodies.
Presta LG
Curr Opin Immunol; 2008 Aug; 20(4):460-70. PubMed ID: 18656541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
